Patent ID: 9198928
Filing Date: 2015-12-01
Classification: A61K,A61P,Y02A

Abstract:
1. A method for treating (i) a bacterial infection in a subject, or (ii) a disease associated with a bacterial infection or a bacterial imbalance in a subject, comprising: topically administering a composition comprising sNAG nanofibers to a subject in need thereof, wherein (a) the sNAG nanofibers were produced by irradiation of poly-N-acetylglucosamine or a derivative thereof, and more than 50% of the sNAG nanofibers are no greater than 15 μm in length, or (b) the sNAG nanofibers were produced by irradiation of poly-N-acetylglucosamine or a derivative thereof with a dose of irradiation that reduces the average length of the sNAG nanofibers to less than 15 μm in length, and wherein the sNAG nanofibers do not have an effect on bacterial growth or survival of